RxDoctor Payments Data

Vipul Mangal, MD

Pain Medicine · Oxon Hill, MDNPI 1336305002

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.1%), royalties or licence payments and consulting fees — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Aurora Spine, Inc. at 52.1% of the total. Among pain medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$764,193in general payments, 2019–2025

Across 1,248 payments — averaging $612.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aurora Spine, Inc.$398K
  • Medtronic$351K
  • Abbott$4K
  • Boston Scientific$3K
  • Relievant Medsystems, Inc.$1K
  • Stimwave Technologies Incorporated$829
  • plus $5K from 39 others
$31,904in research payments, 2019–2025

Across 6 payments — averaging $5317.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$32K

What the payments were for

  • Royalty or licence$220,32429%
  • Consulting fees$192,98825%
  • Speaking & faculty fees$299,07239%
  • Grants$10,0001%
  • Travel & lodging$11,4401%
  • Food & beverage$30,3214%
  • Education$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$764,193 in reported general payments places this provider in the 95th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$804,254
Medicare patients
2,710
Services billed
6,154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen85$1,120
Oxycodone Hcl51$795
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$361
Gabapentin21$215
Cyclobenzaprine Hcl16$139
Mupirocin15$118
Tramadol Hcl27$107
Meloxicam11$64

Paid to pharmacies, not to this prescriber.

Other pain medicine in Oxon Hill

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →